Adam Sayer

Adam Sayer is President and Chief Executive Officer of Lyndra Therapeutics. He also serves on the company’s Board of Directors.

Mr. Sayer brings extensive healthcare ecosystem knowledge and a proven track record of operational excellence to Lyndra's mission of bringing the first-ever long-acting oral medicines to market. His experience spans strategy, business transformation and cross-functional team leadership.

Prior to joining Lyndra, Mr. Sayer served as Chief Transformation Officer at Envision Healthcare, where he oversaw strategy, transformation and payer negotiations. Previously, he spent nearly four years as a consultant at Boston Consulting Group, where he advised clients across various healthcare sectors including pharmaceuticals, medical technology and payer services.

Mr. Sayer earned his Master of Business Administration from the University of Michigan and his Bachelor's degree in economics from Brigham Young University.

Outside of work, Mr. Sayer enjoys spending time with his family. He is an avid Formula 1 racing enthusiast and film buff.